• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

登记处、风险计算器与风险调整后的结果:当前应用、局限性及未来前景

Registries, Risk Calculators, and Risk-Adjusted Outcomes: Current Usage, Limitations, and Future Prospects.

作者信息

Holzer Ralf J, Dayton Jeffrey D

机构信息

NewYork-Presbyterian Komansky Children's Hospital, New York, USA.

Weill Cornell Medicine, New York, USA.

出版信息

Pediatr Cardiol. 2020 Mar;41(3):443-458. doi: 10.1007/s00246-020-02300-7. Epub 2020 Mar 20.

DOI:10.1007/s00246-020-02300-7
PMID:32198591
Abstract

Small study sizes are a limiting factor in assessing outcome measures in pediatric cardiology. It is even more difficult to assess the outcomes of congenital catheterizations where the sample sizes are even smaller, particularly on a individual institutional level. The creation of multicenter registries is a method by which investigators can pool data to better assess quality and outcome measures of these procedures. No registry is perfect with several being available today, each with its own strengths and weaknesses. In addition, there are a multitude of methods currently used to assess quality and outcomes from the data contained in these registries, each having its own limitations as well. Nonetheless, multicenter registrities remain one of the best available options to improve the quality of care for pediatric interventional cardiac catheterization. Below, we provide an overview of the current state of quality assessment/improvement in pediatric interventional cardiology including a review of the available registrities and the metrics used to measure quality of care and outcomes.

摘要

小型研究规模是评估儿科心脏病学结果指标的一个限制因素。在评估先天性导管插入术的结果时更加困难,因为其样本量更小,尤其是在单个机构层面。建立多中心登记系统是一种方法,研究者可以通过该方法汇总数据,以更好地评估这些手术的质量和结果指标。目前没有一个登记系统是完美的,如今有好几个登记系统可供使用,每个都有其优缺点。此外,目前有多种方法用于评估这些登记系统中所包含数据的质量和结果,每种方法也都有其局限性。尽管如此,多中心登记系统仍然是提高儿科介入性心导管插入术护理质量的最佳可用选择之一。下面,我们概述了儿科介入性心脏病学质量评估/改进的现状,包括对可用登记系统以及用于衡量护理质量和结果的指标的综述。

相似文献

1
Registries, Risk Calculators, and Risk-Adjusted Outcomes: Current Usage, Limitations, and Future Prospects.登记处、风险计算器与风险调整后的结果:当前应用、局限性及未来前景
Pediatr Cardiol. 2020 Mar;41(3):443-458. doi: 10.1007/s00246-020-02300-7. Epub 2020 Mar 20.
2
Using Data to Improve Quality: the Pediatric Cardiac Care Consortium.利用数据提升质量:儿科心脏护理联盟
Congenit Heart Dis. 2016 Jan-Feb;11(1):19-25. doi: 10.1111/chd.12297. Epub 2015 Oct 8.
3
Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of cardiology.评估先天性和小儿心脏病患者治疗结果的数据库——心脏病学视角
Cardiol Young. 2008 Dec;18 Suppl 2:116-23. doi: 10.1017/S1047951108002825.
4
IMPACT Registry and National Pediatric Cardiology Quality Improvement Collaborative: Contributions to Quality in Congenital Heart Disease.IMPACT注册研究与国家儿科心脏病学质量改进协作组:对先天性心脏病质量的贡献。
World J Pediatr Congenit Heart Surg. 2019 Jan;10(1):72-80. doi: 10.1177/2150135118815059.
5
Implementation of Methodology for Quality Improvement in Pediatric Cardiac Catheterization: A Multi-center Initiative by the Congenital Cardiac Catheterization Project on Outcomes-Quality Improvement (C3PO-QI).儿科心脏导管插入术质量改进方法的实施:先天性心脏导管插入术结果-质量改进项目(C3PO-QI)的多中心倡议
Pediatr Cardiol. 2016 Dec;37(8):1436-1445. doi: 10.1007/s00246-016-1454-z. Epub 2016 Aug 8.
6
Standardizing radiation dose reporting in the pediatric cardiac catheterization laboratory-a multicenter study by the CCISC (Congenital Cardiovascular Interventional Study Consortium).小儿心导管实验室辐射剂量报告的标准化——先天性心血管介入研究联盟(CCISC)的一项多中心研究
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):785-93. doi: 10.1002/ccd.25467. Epub 2014 Mar 18.
7
The Multicenter Pediatric and Adult Congenital EP Quality (MAP-IT) Initiative-rationale and design: report from the pediatric and congenital electrophysiology society's MAP-IT taskforce.多中心儿科和成人先天性心律失常诊疗质量(MAP-IT)倡议——基本原理与设计:儿科和先天性心律失常电生理学会MAP-IT特别工作组报告
Congenit Heart Dis. 2013 Sep-Oct;8(5):381-92. doi: 10.1111/chd.12084. Epub 2013 May 13.
8
Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry.调整与小儿及先天性心脏导管插入术相关的风险:来自国家心血管数据注册机构(NCDR)IMPACT注册库的报告。
Circulation. 2015 Nov 17;132(20):1863-70. doi: 10.1161/CIRCULATIONAHA.114.014694. Epub 2015 Oct 19.
9
Combining Congenital Heart Surgical and Interventional Cardiology Outcome Data in a Single Database: The Development of a Patient-Centered Collaboration of the European Congenital Heart Surgeons Association (ECHSA) and the Association for European Paediatric and Congenital Cardiology (AEPC).将先天性心脏病外科和介入心脏病学的结果数据合并到一个单一数据库中:欧洲先天性心脏病外科医生协会 (ECHSA) 和欧洲儿科和先天性心脏病协会 (AEPC) 的以患者为中心的合作的发展。
World J Pediatr Congenit Heart Surg. 2023 Jul;14(4):464-473. doi: 10.1177/21501351231168829.
10
Developing tools to measure quality in congenital catheterization and interventions: the congenital cardiac catheterization project on outcomes (C3PO).开发用于测量先天性导管插入术和干预质量的工具:先天性心脏导管插入术结果项目(C3PO)。
Methodist Debakey Cardiovasc J. 2014 Apr-Jun;10(2):63-7. doi: 10.14797/mdcj-10-2-63.

引用本文的文献

1
Congenital Cardiac Catheterization in Low- and Middle-Income Countries: The International Quality Improvement Collaborative Catheterization Registry.低收入和中等收入国家的先天性心脏病导管插入术:国际质量改进协作导管插入术登记处
JACC Adv. 2023 May 24;2(4):100344. doi: 10.1016/j.jacadv.2023.100344. eCollection 2023 Jun.
2
Prevention of Prosthetic Joint Infection: From Traditional Approaches towards Quality Improvement and Data Mining.人工关节感染的预防:从传统方法到质量改进与数据挖掘
J Clin Med. 2020 Jul 11;9(7):2190. doi: 10.3390/jcm9072190.

本文引用的文献

1
Failure to Rescue as an Outcome Metric for Pediatric and Congenital Cardiac Catheterization Laboratory Programs: Analysis of Data From the IMPACT Registry.未能抢救成功作为儿科和先天性心脏病导管实验室项目的结果指标:来自 IMPACT 注册中心的数据分析。
J Am Heart Assoc. 2019 Nov 5;8(21):e013151. doi: 10.1161/JAHA.119.013151. Epub 2019 Oct 17.
2
Validation and refinement of the catheterization RISk score for pediatrics (CRISP score): An analysis from the congenital cardiac interventional study consortium.验证和改进小儿经导管介入治疗风险评分(CRISP 评分):先天性心脏病介入研究联盟的分析。
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):97-104. doi: 10.1002/ccd.27837. Epub 2018 Sep 9.
3
Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study.
经导管封堵房间隔缺损后心脏侵蚀的相关危险因素:一项病例对照研究。
Circulation. 2016 May 3;133(18):1738-46. doi: 10.1161/CIRCULATIONAHA.115.019987. Epub 2016 Mar 21.
4
The National Cardiovascular Data Registry Voluntary Public Reporting Program: An Interim Report From the NCDR Public Reporting Advisory Group.国家心血管数据注册中心自愿公开报告项目:来自NCDR公开报告咨询小组的中期报告。
J Am Coll Cardiol. 2016 Jan 19;67(2):205-215. doi: 10.1016/j.jacc.2015.11.001. Epub 2015 Nov 18.
5
CRISP: Catheterization RISk score for Pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC).CRISP:儿科导管插入术风险评分:先天性心脏介入研究联盟(CCISC)的报告。
Catheter Cardiovasc Interv. 2016 Feb 1;87(2):302-9. doi: 10.1002/ccd.26300. Epub 2015 Nov 3.
6
Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry.调整与小儿及先天性心脏导管插入术相关的风险:来自国家心血管数据注册机构(NCDR)IMPACT注册库的报告。
Circulation. 2015 Nov 17;132(20):1863-70. doi: 10.1161/CIRCULATIONAHA.114.014694. Epub 2015 Oct 19.
7
Characteristics and safety of interventions and procedures performed during catheterisation of patients with congenital heart disease: early report from the national cardiovascular data registry.先天性心脏病患者导管插入术期间所实施干预措施及操作的特点与安全性:来自国家心血管数据登记处的早期报告
Cardiol Young. 2016 Aug;26(6):1202-12. doi: 10.1017/S1047951115002218. Epub 2015 Oct 12.
8
Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry.先天性心脏病常见介入操作的程序结果和安全性:国家心血管数据注册中心的初步报告。
J Am Coll Cardiol. 2014 Dec 16;64(23):2439-51. doi: 10.1016/j.jacc.2014.09.045.
9
Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality.先天性心脏病心导管检查的质量指标:30天死亡率的效用
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):104-10. doi: 10.1002/ccd.25683. Epub 2014 Oct 7.
10
Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease.先天性心脏病心导管检查期间危及生命的不良事件的发生率及处理
Pediatr Cardiol. 2014 Jan;35(1):140-8. doi: 10.1007/s00246-013-0752-y. Epub 2013 Jul 31.